A critical discovery in cancer investigation is arising with the use of mini-antibodies to reactivate mutated p53. This crucial cancer inhibitor protein is frequently disabled in several types of tumors, causing https://todaybookmarks.com/story22109237/mini-antibodies-restore-tumor-suppressor-p53-new-potential-pathway-for-cancer-treatment